Share-based Payment Arrangement, Expense in USD of BIODESIX INC from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIODESIX INC quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2019 to Q3 2025.
  • BIODESIX INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.05M, a 30.5% decline year-over-year.
  • BIODESIX INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4.33M, a 32.9% decline year-over-year.
  • BIODESIX INC annual Share-based Payment Arrangement, Expense for 2024 was $6.64M, a 23.5% increase from 2023.
  • BIODESIX INC annual Share-based Payment Arrangement, Expense for 2023 was $5.37M, a 9.86% decline from 2022.
  • BIODESIX INC annual Share-based Payment Arrangement, Expense for 2022 was $5.96M, a 20.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIODESIX INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.33M $1.05M -$462K -30.5% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 $4.79M $1.04M -$179K -14.7% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $4.97M $972K -$1.67M -63.2% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $6.64M $1.27M +$184K +17% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 $6.45M $1.52M +$561K +58.8% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025
Q2 2024 $5.89M $1.22M +$161K +15.2% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $5.73M $2.64M +$359K +15.7% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 $5.37M $1.08M -$996K -48% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $6.37M $954K -$216K -18.5% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2024
Q2 2023 $6.59M $1.06M -$311K -22.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $6.9M $2.28M +$935K +69.5% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 $5.96M $2.08M +$810K +63.9% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2024
Q3 2022 $5.15M $1.17M -$216K -15.6% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $5.37M $1.37M +$829K +154% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $4.54M $1.35M -$406K -23.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $4.94M $1.27M 01 Oct 2021 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 $1.39M +$1.29M +1286% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $539K +$484K +880% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $1.75M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 $100K +$55K +122% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $55K 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q3 2019 $45K 01 Jul 2019 30 Sep 2019 10-Q 10 Dec 2020

BIODESIX INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.64M +$1.27M +23.5% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 $5.37M -$588K -9.86% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 $5.96M +$1.02M +20.6% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2024
2021 $4.94M +$1.24M +33.3% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023
2020 $3.71M +$3.54M +2082% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 $170K 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.